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The purpose of this dissertation is to define how the pathways of apoptosis and 
extrusion connect. These studies employed MDCK and HBE in vitro cultured epithelia as 
model systems to explore the ability of different components of the apoptosis pathways to 
participate in the activation of the extrusion response. Because of the ease of their 
manipulation for genetic, pharmacological and cell biology analyses but most importantly 
because their ability to reproduce in vivo apoptotic cellular extrusion, cultured epithelia 
provide a powerful and efficient system to study and dissect the molecular basis of 
apoptotic cellular extrusion.  
In the first part of this dissertation, we established that both intrinsic and extrinsic 
apoptotic pathways activate cellular extrusion and that the contraction force that drives 
cellular extrusion requires caspase activity. Accordingly, we found that necrosis does not 
trigger the cellular extrusion response; nevertheless, necrotic cells are removed from 
epithelia by a passive mechanism that involves forces of the stochastic movement of 
epithelial cells. 
The second part of this dissertation is focused on the regulation of apoptotic cellular 
extrusion by the anti-apoptotic protein Bcl-2. Mutations that increase Bcl-2 protein levels 
result in resistance to cell death, which in turn lead to several malignances in the living 
organism. Here, as a way to complement our studies in the first part of this dissertation, 
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we explore the effect of Bcl-2 on cell junctions, test the ability of HA14-1, a Bcl-2 
inhibitor, to activate cell extrusion and finally we test the ability of this oncogene to 
regulate cellular extrusion in vivo. 
The studies reveal the connection between apoptosis and cellular extrusion: caspase 
activation, a conserved point in the apoptosis pathway where all known apoptotic signals 
converge. The discovery of the requirement of caspases for cellular extrusion reveals a 
new non-apoptotic role for caspases and sets caspase activity as an important checkpoint 
for epithelial cellular removal. These studies also reveal a new passive mechanism by 
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1.1 Cell death mechanisms 
Cell death plays essential roles in living multicellular organisms during development, 
morphogenesis, homeostasis, tissue remodeling, and activation of inflammation during 
the immune response [1, 2]. Moreover, misregulation of cell death has important 
implications for developmental diseases, tumor initiation and progression, 
neurodegenerative diseases (Parkinson’s or Alzheimer’s diseases) and autoimmune 
diseases [3, 4]. Cell death can be classified in three types: Apoptosis, necrosis and 
autophagic cell death (Fig. 1.1). While apoptosis and necrosis are traditionally accepted 
as forms of cell death, the acceptance of autophagic cell death, in which cells digest 
themselves to death as a suicide strategy, is still on debate [5-7]. 
 
1.1.1 Characteristics of apoptosis and necrosis 
During apoptosis, activated caspases, through a controlled process of proteolysis, 
break down and package the dying cell into apoptotic bodies. To avoid immune 
activation, apoptotic bodies do not undergo plasma membrane breakdown and are 
promptly recognized and removed by phagocytic cells. The nucleus undergoes 
condensation (pyknosis) and fragmentation (karyorhexis) and the chromosomal DNA is 
cleaved into 200 basepair inter-nucleosomal fragments [8]. The condensation and 
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blebbing of the dying cell requires actin and myosin dynamics, which consumes high 
levels of ATP [9]. In contrast to apoptosis, necrosis results from ATP depletion. Because 
no energy is available for the organized breakdown of the cell, necrosis is characterized 
by failure to regulate osmosis and cell lysis. Plasma membrane breakdown that occurs in 
necrotic cells allows the release of High Motility Group Box 1 protein (HMGB1), 
responsible for activation of the inflammatory response (Fig. 1.1) [10-12]. Necrotic cells 
exhibit changes in nuclear morphology due to DNA degradation, but they do not have the 
organized chromatin condensation and fragmentation of DNA of apoptotic cells [13]. 
Although necrosis has been thought to be a passive, disorganized form of cell death, it 
has recently emerged as an alternate form of programmed cell death, regulated by the 
same factors that control apoptosis (exposure to apoptotic cytokines and irradiation, Bcl-2 
and heat shock proteins) [13-15]. Moreover, necrosis can be triggered during some 
pathological conditions such as microbial infection and cancer, or during tissue renewal 
and embryogenesis [14]. 
 
1.1.2 Regulation of the apoptotic machinery 
Depending on the death stimulus, a cell may undergo apoptosis via two different 
apoptotic pathways—the extrinsic and the intrinsic pathways (Fig. 1.2) [16, 17]. Both 
pathways ultimately lead to the activation of executioner caspases (caspases-3, -6, and -
7), which directly and indirectly physically break down the apoptotic cell [18].  
To activate the extrinsic pathway, a ligand (such as TNF, Fas-L, and TRAIL) binds 
its respective death receptor, which recruits and oligomerizes adapter molecules that 
activate initiator caspases, caspase-8 and -10 (Fig. 1.2) [19]. Active initiator caspases 
proteolytically activate the executioner caspases, necessary to bring about apoptosis. 
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Type I cells can directly activate executioner caspases upon caspase-8 and -10 activation; 
however, type II cells must amplify the signal from the activated death receptor by 
targeting the mitochondrial pathway of apoptosis (Fig. 1.2) [20, 21]. 
On the other hand, various internal cell death cues trigger the intrinsic pathway by 
signaling through the mitochondrial pathway of apoptosis (Fig. 1.2) [22]. When death 
signals override survival signals, the mitochondrial outer membrane becomes permeable, 
releasing cytochrome c, the apoptosis-inducing factor (AIF), Endo G, Omi and Diablo 
into the cytoplasm (Fig.1.3). Once in the cytoplasm, cytochrome c forms a 
macromolecular complex with apaf-1 and procaspase-9 called the apoptosome, which 
facilitates activation of the initiator caspase, caspase-9 (Fig.1.3) [23]. While active 
caspase-9 activates executioner caspases, Omi and Diablo facilitates caspase activation 
by antagonizing the inhibitors of apoptosis proteins (IAPs) (Fig.1.3). AIF and Endo G 
activate DNA condensation and degradation (Fig.1.3). If caspases are genetically or 
pharmacologically inhibited, AIF and Endo G can still promote caspase-independent 
death [24, 25]. 
The Bcl-2 family of proteins regulates mitochondrial outer membrane 
permeabilization (MOMP) (Fig.1.2) [26-28]. To date, a total of 25 genes have been 
identified in this family [29, 30]. Based on their Bcl-2 homology (BH) domains, the gene 
products of this family are classified in multidomain and BH3-only proteins; and based 
on their function, they are classified in anti-apoptotic and pro-apoptotic (Fig. 1.4). Anti-
apoptotic proteins such as Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and Bfl-1 are only multidomain, 
generally having four BH domains (BH1-4). Conversely, pro-apoptotic proteins contain 
either two or three BH domains (BH1-3) (such as Bax, Bak and Bok) or are single BH3-
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only containing (such as Bim, Bid, Bad, Bik, Bmf, Noxa, Puma and Hrk) (Fig 1.4) [31, 
32]. Once activated, pro-apoptotic multidomain proteins oligomerize to form pores in the 
outer mitochondrial membrane driving MOMP and the release of mitochondrial apoptotic 
factors into the cytoplasm (Fig. 1.3) [33]. To prevent MOMP, anti-apoptotic proteins bind 
pro-apoptotic proteins and inhibit their oligomerization (Fig. 1.2). The result of this battle 
between pro-apoptotic and anti-apoptotic proteins will determine whether the cell will 
survive or die [34]. The precise mechanism by which multidomain pro-apoptotic proteins 
are activated remains unclear. It is believed that BH3-only proteins activate multidomain 
pro-apoptotic proteins directly by binding, inducing their conformational change into 
their active form, or indirectly by engaging and neutralizing anti-apoptotic proteins [35]. 
Since inhibition of anti-apoptotic proteins is not sufficient for activation of pro-apoptotic 
proteins, but requires the BH3-only proteins Bid or Bim, a combination of both models 
may be important for apoptosis initiation [36]. 
 
1.2 Apoptotic cellular extrusion 
Epithelia, formed by multiple or a single layer of cells, provide a protective barrier for 
the tissues and organs they encase. During development and later throughout life, the 
cells comprising the epithelium undergo dramatic turnover [37]. Epithelia are frequently 
exposed to toxins, inflammatory cytokines, or pathogens resulting in apoptosis or 
necrosis that could potentially damage the epithelium, and compromise its function as a 
protective barrier (Fig. 1.5) [38, 39]. Poor epithelial barrier function could lead to 
malformations in the developing embryo, edema, tissue damage, inappropriate signaling, 
inflammation, and severe infections or sepsis in the adult organism. However, even when 
a significant proportion of cells become apoptotic in the epithelia, the barrier is still 
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maintained in all epithelia by a process termed cellular extrusion. During extrusion, an 
apoptotic cell signals its epithelial neighbors to form an actin and myosin contractile ring 
that squeezes the dying cell out of the monolayer while simultaneously replacing the 
space of exiting dying cell, thereby preventing the formation of a gap in the epithelium  
(Fig. 1.5) [40].  
Apoptotic cell extrusion occurs in all epithelia examined including the retinal pigment 
epithelium of chick embryos, embryonic epidermis of chick, mouse, and Drosophila, 
intestinal villi (Fig. 1.6), and can be modeled in tissue culture epithelia [40-44]. Although 
inducing apoptosis in epithelia activates extrusion, it is not clear how extrusion and 
apoptosis are connected or what factors initiate the formation and contraction of the 
actomyosin extrusion ring. Two models were proposed to explain how extrusion occurs 
during apoptosis. The cell autonomous model proposed by Mills et al. [9] suggested that 
extrusion results from contractile forces involved in apoptotic cell condensation and 
blebbing (Fig. 1.7). During apoptosis, caspases activate actomyosin regulators such as 
ROCK1, Gas2 and LIMK1 [45-49]. As a result, the apoptotic cell undergoes dramatic 
actomyosin changes forming a contraction ring inside the dying cell. The forces resulted 
by the contractions of this ring lead to cell blebbing and condensation. Mills et al. [9] 
state that these contractions also drag the neighbor cells close to fill the gap the apoptotic 
cell would leave. This model proposes that extrusion is absolutely dependent on the dying 
cell and there is no participation of the neighbor cells during this process (Fig. 1.7). On 
the other hand, the noncell autonomous model proposes that removal of the apoptotic cell 
relies on the formation and contraction of an actomyosin ring in the neighbor cells. By 
using a cell addition assay, where apoptotic or live cells are added to epithelial 
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monolayers, Rosenblatt et al. [40] found that addition of early apoptotic cells to a live 
monolayer can induce actin assembly in the cells they contact, suggesting that the 
apoptotic cell can trigger assembly of the actin extruding ring in the neighboring cells 
(Fig. 1.8) [40]. In addition, our lab has recently identified sphingosine-1-phosphate as the 
signal the apoptotic cell sends to its neighbors to execute their removal from the 
epithelium, further supporting this model (unpublished data).  
While this model suggests that apoptotic cells can signal extrusion, it is still unclear 
how it does so. Additionally, is apoptosis required to initiate extrusion or can extrusion 
occur independently of apoptosis? If so, do both intrinsic and extrinsic apoptotic stimuli 
activate extrusion? Which apoptotic signals are important for activating extrusion? What 
component(s) of the apoptotic machinery triggers the extrusion response? Can other 
forms of cell death such necrosis activate cell extrusion? 
In my dissertation, by testing different apoptotic stimuli, I have found that any 
intrinsic or extrinsic apoptotic stimulus trigger extrusion. Additionally, I found that 
extrusion requires caspase activation for proper formation and contraction of the 
actomyosin ring. Although necrotic cells, resulting from caspase inhibition, do not 




































Figure 1.1 Mechanisms of cell death.  
Cells can die through three types of cells death: Apoptosis, necrosis and autophagic cell 
death. During apoptosis, the nucleus and the cell undergo condensation and 
fragmentation, the plasma membrane does not become permeable and there is no release 
of HMGB1 (black spot). During necrosis, the plasma membrane becomes permeable and 
HMGB1 is released from the cell (absence of black spot in the gray nucleus). During 
autophagic cell death, the plasma membrane remains intact, HMGB1 is released and 













Figure 1.2 Apoptosis signaling pathways. 
The intrinsic pathway senses different forms of cell stress (such as DNA damage) and 
targets the mitochondrial pathway for activation of apoptosis. On the mitochondria, the 
Bcl-2 family of proteins regulates mitochondrial permeabilization and cytochrome c 
release (see text for details). On the other hand, the extrinsic pathway is activated by 
binding of ligands on the death receptor. This signal is transduced to directly activate 


















Figure 1.3 Apoptosis regulation by the mitochondrial pathway 
Once the mitochondrial outer membrane is permeabilized, several factors participate in 
the activation of executioner caspases 3, 6 and 7. While Caspase-Activated DNase (CAD) 
along with AIF and Endo G participate in the degradation of DNA, executioner caspases 















Figure 1.4 The Bcl-2 family members. 
Based on their function, members of the Bcl-2 family of proteins are classified into pro-
survival or anti-apoptotic and pro-apoptotic. Also based on their Bcl-2 homology domain 
(BH), they are classified into multidomain or BH3-only proteins. TM stands for 














Figure 1.5 Apoptotic cellular extrusion. 
Cells forming epithelia are exposed to an environment that induces cell death (a). 
Apoptosis could compromise epithelial protective barrier as apoptotic cells (blue) bleb 
and also are recognized and removed by macrophages (b). During extrusion, the dying 
cell signals (blue arrows) its neighbor to form actomyosin ring (red). Contraction of the 
ring squeezes the apoptotic cell out of the epithelium and brings the neighbor cells to seal 













Figure 1.6 The biological roles of apoptotic cellular extrusion  
Apoptotic cellular extrusion participates during developing of the limbs of chick embryos 
(a) and tracheal dorsal branches in Drosophila embryos (b). It drives dorsal closure 
during Drosophila development (c), and it maintains the proper compartment retinal 
pigment epithelium provides to the photoreceptors in the chick retina (d). Also during 
homeostasis, it maintains the protective barrier of the rabbit intestinal villus tip (e). Blue 
















Figure 1.7 The cell autonomous model for apoptotic cellular extrusion 
During apoptosis, cells undergo dramatic actomyosin changes forming a contraction ring 
inside the dying cell. The forces resulted by these contractions lead to cell blebbing and 
condensation. The cell autonomous model proposed by Mills et al. [9] states that the 
contractions occurring during apoptosis will drag the neighbor cells close to fill the gap 
the apoptotic cell would leave. This mechanism is absolutely dependent on the dying cell 









Figure 1.8 The noncell autonomous model for apoptotic cellular extrusion. 
In a cell addition assay, live or apoptotic cells are added to cell epithelial monolayers (a). 
When live cells are added, little or none actin cables (white arrow) are formed in the 
monolayer where the cell added is contacting. When apoptotic cells in an early stage of 
apoptosis are added, a very intense spot of actin cables (white arrow) are formed in the 
monolayer where the apoptotic cell is contacting. No actin cables are formed when 
apoptotic cells in a late stage of apoptosis are added to the monolayer (b). The noncell 
autonomous model states that at an early stage of apoptosis, the dying cell will send a 
signal (sphingosine-1-phosphate [S1P]) to the neighbor cells to form a ring of 
actomyosin. Probably like a muscle sarcomere (inset), this ring contracts, removing the 
apoptotic cell out of the epithelium and bringing the neighbor cells to fill the gap the 
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Abstract Cellular extrusion is a mechanism that removes
dying cells from epithelial tissues to prevent compromising
their barrier function. Extrusion occurs in all observed
epithelia in vivo and can be modeled in vitro by inducing
apoptosis in cultured epithelial monolayers. We established
that actin and myosin form a ring that contracts in the
surrounding cells that drives cellular extrusion. It is not
clear, however, if all apoptotic pathways lead to extrusion
and how apoptosis and extrusion are molecularly linked.
Here, we ﬁnd that both intrinsic and extrinsic apoptotic
pathways activate cellular extrusion. The contraction force
that drives cellular extrusion requires caspase activity.
Further, necrosis does not trigger the cellular extrusion
response, but instead necrotic cells are removed from epi-
thelia by a passive, stochastic movement of epithelial cells.
Keywords Extrusion  Apoptosis  Contraction ring 
Actomyosin dynamics  Caspases
Introduction
During development and throughout adulthood, cells
forming epithelial tissues undergo extensive turnover via
cell division and death [1]. Aside from homeostatic death,
epithelia are frequently exposed to toxins, inﬂammatory
cytokines, pathogens or other forms of stress that lead to
increased apoptosis or necrosis [2, 3] that could damage the
epithelium. This damage could compromise the protective
barrier that epithelia provide the organs and tissues they
encase. Poor epithelial barriers could lead to malformations
in developing embryos or edema, tissue damage, chronic
inﬂammation and infections in adults. However, even when
large numbers of epithelia cells become apoptotic, the
barrier is still maintained using a process termed ‘cellular
extrusion’. During extrusion, an apoptotic cell signals its
neighbors to form an actin and myosin contractile ring that
simultaneously squeezes the dying cell out of the monolayer
replacing the space the apoptotic cell leaves, thereby pre-
venting any gaps from forming within the epithelium [4].
Several studies have linked cellular extrusion and
apoptosis in vivo and in vitro [4–9]. Two models proposed
that apoptosis could drive cellular extrusion, yet neither
model has been examined experimentally. In one model,
Mills et al. [10] suggested that extrusion results from the
contractile forces that drive apoptotic cell blebbing. In the
other, Peralta-Soler et al. [6] suggested the apoptotic cell
would signal reorganization of actin ﬁlaments and cell
junctions at the interface between the dying cell and its
neighbors to orchestrate cell extrusion. Later, Rosenblatt
et al. [4], through a cell addition assay, demonstrated that
early apoptotic cells induce the formation of actin cables
on cells in a monolayer, suggesting that the apoptotic cell
signals the neighboring cells to induce the actomyosin ring
to form and contract. This was an important step for
understanding how apoptotic cells might activate extrusion,
yet several questions remain. How does apoptosis trigger
extrusion and which apoptotic signals are important for
activating extrusion? Is extrusion activated in response to
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both intrinsic and extrinsic apoptotic stimuli? Is apoptosis
required to initiate extrusion or can extrusion occur inde-
pendently of apoptosis? Can other forms of cell death such
necrosis activate cell extrusion?
Here, we ﬁnd that extrusion can be triggered by either
intrinsic or extrinsic apoptotic stimuli. By investigating
different steps in these apoptotic pathways, we found that
completion of extrusion requires caspase activation.
Although necrotic cells resulting from caspase inhibition
do not extrude, they are removed from epithelia by sto-
chastic movement of epithelial cells.
Materials and methods
Cell culture
MDCK II cells (gift from K. Matlin, University of Chicago,
Chicago, IL) were cultured in Dulbecco’s Modiﬁed Eagle
Medium (DMEM) high glucose (Invitrogen 11965-092)
with 5% FBS, 2 mM L-glutamine, 50 U/ml penicillin,
50 lg/ml streptomycin (all from Invitrogen) at 5% CO2,
37C. 16-HBE-14o (gift from D. Gruenert, California
Paciﬁc Medical Center, San Francisco, CA) were cultured
in Minimum Essential Media (MEM) low glucose (Invitro-
gen 11095-080) with 5% FBS, 2 mM L-glutamine, 50 U/ml
penicillin, 50 lg/ml streptomycin in a ﬂask coated with a
solution of human ﬁbronectin type I (BD Biosciences),
bovine collagen I (Purecol; Inamed biomaterials), and BSA
(Invitrogen) at 5% CO2, 37C.
Induction of cell death
To induce apoptosis, MDCK monolayers or HBE bilayers
were treated with 120 mJ/cm2 short-wave (UV-C) light,
using a Spectrolinker (Spectroline) and incubated for 2 h
after irradiation or by treating with 500 lM etoposide
(Sigma-Aldrich) for 5 h or 100 ng/ml superKiller TRAIL
(Enzo Life Sciences) along with 100 ng/ml Cyclohexamide
(Calbiochem) for 5 h. In some experiments, MDCK cells
were pre-treated with 50 lM z-VAD-fmk (Promega) or
0.1% DMSO (Sigma) before inducing apoptosis.
Cell staining
Cells were ﬁxed with 4% formaldehyde in PBS for 20 min,
permeabilized for 5 min with 0.5% Triton in PBS, rinsed
three times with 0.1% Triton in PBS, and blocked with
AbDil (PBS with 0.1% Triton X-100 and 2% BSA) for
20 min before incubating with primary antibodies. Cells
were then incubated with the following primary antibodies
(diluted in AbDil) for 1 h: 1:100 mouse monoclonal anti-
Bax clone 6A7 (Sigma), 1:200 rabbit monoclonal anti
active caspase-3 (BD pharmigen), 1:100 rabbit polyclonal
anti cytochrome c (Santa Cruz), mouse monoclonal anti
cytochrome c (Abcam), 1:50 monoclonal mouse anti
HMGB1 (Sigma) and 1:100 polyclonal rabbit anti AIF
(Cell Signaling). After washing coverslips three times in
0.1% Triton X-100, coverslips were incubated in secondary
antibodies (all diluted 1:100 in AbDil): Alexa Fluor 488
goat anti-mouse, Alexa Fluor 568 goat anti-mouse, Alexa
Fluor 488 goat anti-rabbit, Alexa Fluor 568 goat anti-
rabbit and Alexa Fluor 647 goat anti-rabbit (all from
Molecular probes, Invitrogen). Along with secondary
antibodies, we incubated the cells with 1 lg/ml Hoescht
33342 (Sigma-Aldrich) and 0.25 lg/ml Alexa Fluor 568
phalloidin or 0.25 lg/ml Alexa Fluor 647 phalloidin
(Molecular Probes, Invitrogen). After incubation with
secondary antibody for 45 min, the coverslips were rinsed
once with 0.1% Triton in PBS and then mounted on a
micro slide (Gold Seal Products) using ProLong Gold
antifade reagent (Invitrogen).
Microscopy
Fluorescence micrographs cells were obtained using a
Leica DM 6000B microscope captured with a Micromax
charge-coupled device camera (Roper Scientiﬁc). IP Lab
Software was used to control the camera and to process
images. All images were processed further using Photo-
shop (Adobe) and Illustrator (Adobe) software. Movies
were made with an Olympus IX81 spinning disk micro-
scope with a Weather Station incubation chamber, prior
motorized stage, ZDC-laser focus, and motorized objec-
tives for Z-sectioning. Slidebook TM 5.0 software (3i
intelligent Imaging Innovations) was used to control the
camera and to process images. Images were later processed
using ImageReady software (Adobe).
Immunoblot analysis
Antibodies used for immunoblot analysis included poly-
clonal rabbit anti-Bax (Santa Cruz), monoclonal rabbit
anti-Bak (Abcam), monoclonal mouse anti-Bcl-2 (Abcam),
polyclonal rabbit anti-GFP (Invitrogen) and Monoclonal
mouse anti-alpha tubulin (Sigma) diluted to 1:10,000 in
PBST (0.05% Tween 20 in PBS) with 5% milk.
DNA constructs
Human Bcl-2 alpha isoform ORF (Open Biosystems) was
PCR cloned and recombined into the donor vector
pDONR221 (Invitrogen) following company’s instructions.
The entry vector, pDONR-Bcl2-221, was then recombined
with the retroviral vector pMIG [11] modiﬁed to function




The expression vector pMIG-Bcl2 and the empty pMIG
vector were used to produce retroviral particles. We syn-
thesized Bax and Bak shRNA oligos: GCUCUGAGCAGA
UCAUGAA and CCCAUUCACUACAGGUGAA, respec-
tively [13] and cloned them into the lentiviral vector
pLL5.0 (Gift from Dr. James Bear [14]). The generated
vectors pLL5.0 Bax shRNA and pLL5.0 Bak shRNA along
with the control vector pLL5.0 N.S. shRNA (Also a gift
from Dr. James Bear) were used to make lentiviral parti-
cles. The gene fusion rat HMGB1-EGFP construct (Gift
from Dr. Marco Bianchi [15]) was PCR cloned into the
retroviral vector pMSCVhyg (Clontech).
Statistical analysis
The statistical analysis of data collected from three inde-
pendent experiments was performed using the parametric
unpaired two-tailed t test. In each graph, P values are
shown and error bars are Standard Error of the Mean
(SEM), unless indicated differently.
Results
Both intrinsic and extrinsic apoptotic stimuli elicit
cellular extrusion in epithelial monolayers
To determine if different apoptotic pathways could trigger
cell extrusion and to establish where in the apoptotic
pathway extrusion is activated, we investigated whether a
variety of intrinsic and extrinsic apoptotic stimuli activate
extrusion in Madin-Darby Canine Kidney (MDCK) cell
monolayers. Although previous studies have found that
both extrinsic and intrinsic pathways can activate extru-
sion, these studies were done in different cell types and
with only one type of stimulus [4, 6, 7]. We treated MDCK
monolayers with either etoposide, a topoisomerase II
inhibitor that causes double-stranded DNA breaks and
activates the intrinsic death pathway, or TRAIL (Tumor
Necrosis Factor (TNF)-related apoptosis-inducing ligand)
to activate the extrinsic pathway. We then assayed for the
number of cells undergoing apoptotic cellular extrusion by
counting the number of cells with a contractile actin ring
that stained positively for the apoptosis marker, active
caspase-3 (Fig. 1a–c). Both treatments increased the per-
centage of cells undergoing apoptotic cellular extrusion
compared to controls (Fig. 1b, c). To determine the treat-
ment at which apoptotic cellular extrusion is maximized,
we used increasing doses of apoptotic stimuli. Doses higher
than 1 mM etoposide or 500 lg/ml TRAIL destroyed the
monolayer integrity, which impaired the ability of cells to
extrude (Figs. S1, S2 in Supplementary Material). There-
fore, compared to apoptosis studies in single cells,
apoptotic cell extrusion can only be assessed when between
2 and 8% of the monolayer undergoes apoptosis. Because
of this, all of our extrusion assays are conducted within this
range of percentage of apoptotic cell extrusion.
Additionally, treatment with camptothecin, a topoiso-
merase I inhibitor, or Fas ligand (Fas-L), which activate the
intrinsic or extrinsic pathways of cell death respectively,
produced similar results to those of etoposide and TRAIL
(data not shown). The same treatments in another epithelial
cell line, human bronchial (HBE), gave similar results
(Figs. 2e, 3d) and all cells undergoing apoptosis also
undergo extrusion. Together, these results suggest that
multiple types of epithelia can trigger extrusion in response
to a variety of intrinsic or extrinsic apoptotic stimuli. These
results also suggest that the extrusion pathway should ini-
tiate downstream of where the extrinsic and intrinsic
apoptosis pathways converge.
Both intrinsic and extrinsic apoptotic pathways target
the mitochondrial pathway during apoptotic cellular
extrusion
The extrinsic apoptotic pathway can directly activate
executor caspases such as caspase 3 through the initiator
caspases 8 and 10, skipping the mitochondrial pathway
[16–18]. However, the extrinsic pathway does have the
ability to induce mitochondrial outer membrane perme-
abilization (MOMP) for release of mitochondrial apoptotic
factors such as cytochrome c and Smac/Diablo that will
facilitate the activation of caspases and enhance the exe-
cution of apoptosis. This process occurs through the pro-
teolytic activation of the BH3-only protein Bid by caspase
8, which in turn activates the multidomain pro-apoptotic
protein Bax. Activated Bax translocates to the mitochon-
dria where it oligomerizes to form pores and permeabilize
the mitochondrial outer membrane [16, 19]. Therefore,
since both intrinsic and extrinsic apoptotic pathways have
the ability to target the mitochondria during apoptosis, it is
possible that the mitochondria, through the release of a
sequestered factor, could play a role in the activation of the
extrusion machinery.
To test this possibility, we investigated if extrinsic and
intrinsic stimuli target the mitochondria during apoptotic
cell extrusion by immunostaining MDCK monolayers for
cytochrome c and the activated form of Bax after inducing
apoptosis with either etoposide or TRAIL (Fig. 1d, e, Fig.
S3 in Supplementary Material). All apoptotic extruding
cells, triggered by either etoposide or TRAIL treatment,
show strong staining for the active form of Bax (as rep-
resented in Fig. 1d, Fig. S3a in Supplementary Material).
Cytochrome c staining is also diffuse in all apoptotic
extruding cells analyzed, characteristic of cytoplasmic




when compared to the punctate, mitochondrial staining
seen in live cells (seen in bottom view of Fig 1e, Fig. S3b
in Supplementary Material). These results show that both
the extrinsic and intrinsic pathways activate mitochondrial
permeabilization during apoptotic cell extrusion and sug-
gested that mitochondria might sequester factors required
for activation of the extrusion pathway during apoptosis.
Either overexpression of Bcl-2 or knockdown of Bax
and Bak block cell extrusion via the intrinsic
but not extrinsic apoptotic pathway
To determine the potential role of mitochondria in the
activation of cellular extrusion, we blocked its permeabili-
zation, and evaluated if cellular extrusion was blocked
when the intrinsic pathway of apoptosis was stimulated. To
block MOMP, and therefore the release of mitochondrial
factors during apoptosis, we use two approaches:
overexpression of the anti-apoptotic protein Bcl-2 or
knockdown of the pro-apoptotic genes Bax and Bak. To do
this, we transduced MDCK cells with a vector containing a
Bcl-2-IRES-EGFP cassette or sequentially transduced HBE
cells with vectors containing a Bax shRNA and a Bak
shRNA sequence (Fig. 2a, b). For the respective controls,
we transduced MDCK cells with an empty vector (IRES-
EGFP) or HBE cells with non-speciﬁc shRNA sequence
(Fig. 2a, b). Epithelial monolayers overexpressing Bcl-2 or
with Bax/Bak knockdown were treated with UV-C irradi-
ation or etoposide and scored for their abilities to undergo
apoptosis and extrusion. In addition to apoptosis, overex-
pression of Bcl-2 or downregulation of both Bax and Bak
inhibited cell extrusion (Fig. 2c–e, Fig S4 in Supplementary
Material), suggesting that mitochondria permeabilization is
required for the activation of the extrusion pathway. We
obtained similar results when we over-expressed Bcl-2 in
HBE cells (data not shown). Therefore, the signal that
Fig. 1 Both intrinsic and
extrinsic apoptotic stimuli elicit
cellular extrusion in epithelial
monolayers. MDCK
monolayers treated with DMSO,
etoposide, cycloheximide
(CHX) or TRAIL plus CHX
were ﬁxed and stained for DNA,
actin and active caspase-3 (a).
Insets show a magniﬁed view of
the contraction ring, the
apoptotic extruding cell and the
neighbor cells distributed in a
rosette pattern, characteristic of
extrusion. Apoptotic extruding
cells (a) were quantiﬁed (b,
c) from three independent
experiments. Cells treated with
TRAIL or CHX were stained for
DNA, actin, active caspase-3,
and active Bax (d) or
cytochrome c (e). Cartoons in
(d) illustrate the microscope
focal planes; the bottom view
focuses on the contraction ring
of the extruding cell and the top
view focuses on the cell
extruded out of the layer. Insets
in (e) show the cytochrome c
distribution of a live neighbor
cell (bottom view) and of an
extruding cell (top view). Scale
bars, 10 lm. The number of
cells counted for statistical
analysis in (b) and (c) was as
followed: DMSO (n = 1046),
Etoposide (n = 1449),






initiates extrusion could either be sequestered in the mito-
chondria or activated downstream mitochondrial perme-
abilization (i.e. caspase activation).
Although our data show TRAIL targets the mitochon-
dria during apoptotic cell extrusion, it might not require
MOMP to induce apoptosis, as it can directly activate
executioner caspases via caspase 8 and 10. If the extrusion-
initiating signal is sequestered in the mitochondria, then
blocking MOMP after initiating the extrinsic pathway
should not allow cells to extrude. However, if the extrusion
initiating signal is activated downstream of caspase acti-
vation, then TRAIL-dependent activation of the extrinsic
death pathway should cause both apoptosis and extrusion
even when MOMP is blocked. To test between these
models, we treated MDCK and HBE monolayers with
TRAIL and evaluated cell death and extrusion when
MOMP is blocked by Bcl-2 overexpression or Bax/Bak
knockdown (Fig. 3a–d). Neither overexpression of Bcl-2
nor Bax/Bak knockdown blocked apoptosis induced by
TRAIL treatment, as expected from other studies [16, 18].
Importantly, cell extrusion also occurred in these lines,
favoring the hypothesis that the extrusion-initiating signal
is activated downstream caspase activation.
To verify that TRAIL-induced apoptotic cell extrusion
occurred independently of mitochondrial permeabilization,
we immunostained TRAIL-treated monolayers for active
Bax and cytochrome c (Fig. 3e). Apoptotic extruding cells
from monolayers where Bcl-2 was overexpressed still
showed release of cytochrome c; however, cytochrome c
staining appeared punctate when Bax and Bak were
knocked down (Fig. 3e, right panel insets). Although some
mitochondrial permeability may occur through other
mechanisms (i.e. VDAC) [20, 21], lack of complete diffuse
cytochrome c staining suggested that Bax/Bak knockdown
blocked most of MOMP. Correspondingly, activated Bax
was absent in apoptotic extruding cell where Bax and Bak
were knocked down, yet Bcl-2 overexpression still resulted
in activated Bax staining (Fig. 3e, left panel insets). Failure
Fig. 2 Over-expression of Bcl-2 or knockdown of Bax and Bak
blocks cell extrusion induced by intrinsic apoptosis stimuli. Immu-
noblot analysis of Bcl-2 in MDCK (a) or Bax and Bak in HBE
(b) cells transduced with the indicated constructs. In (a), asterisk
denotes non-speciﬁc immunogen; and in (b), N.S. stand for non-
speciﬁc shRNA. Extrusion in MDCK monolayers with over-expres-
sion of Bcl-2 block cell death and extrusion, where arrows indicate
apoptotic extruding EGFP-positive cells (c). The EGFP-negative cells
in the vector control and Bcl-2 monolayers (c) are internal control
cells. Note that internal control cells are extruding in both Vector and
Bcl-2 monolayers. Scale bars, 10 lm. The number of apoptotic
extruding cells was quantiﬁed (d, e) from three independent
experiments. The P values in (d) and (e) correspond to t test analyses
of the experiments indicated with red bars. The number of cells
counted for statistical analysis in (d) and (e) were as followed: Vector
-UV = 790, Vector ?UV = 619, Bcl2 -UV = 1319, Bcl2
?UV = 1050, NS -UV = 1907, NS ?UV = 2078, Bax/Bak -




of Bcl-2 overexpression to block TRAIL-induced Bax
activation and cytochrome c release suggests that other
anti-apoptotic Bcl-2 family members, rather than Bcl-2,
could efﬁciently inhibit Bax activation and cytochrome c
release triggered by TRAIL (i.e. Bcl-xL, Mcl-1, Bﬂ-1 and
Bcl-w) [22–24]. However, because knockdown of Bak/Bax
blocked both Bax activation and signiﬁcant cytochrome c
release but still allowed apoptotic extrusion to occur; we
Fig. 3 Neither over-expression of Bcl-2 nor Bax/Bak knockdown
blocks cell extrusion induced by extrinsic apoptosis stimuli. Extrusion
in MDCK and HBE monolayers transduced with Bcl-2 or Bax/Bak
shRNAs were treated with TRAIL and CHX (a, b respectively).
Arrows in (a) and (b) show apoptotic extruding cells. In (a), the
arrows in upper panels point to closed actin rings with condensed and
fragmented DNA and those in lower panels show EGFP-positive cells
with caspase-3 activity. The EGFP-negative cells in (a) are internal
control cells. The number of apoptotic extruding cells was quantiﬁed
(c, d) from three independent experiments. The P values in (c) and
(d) correspond to t test analyses of the experiments indicated with red
bars. Monolayers treated with TRAIL and CHX were stained for
DNA, actin, and either active Bax or cytochrome c (e). Bottom views
show actin rings of extruding cells while insets of top views show the
apoptotic extruding cell features. The second of the Bcl-2 panels
shows two adjacent extruding cells positive for active Bax: one
EGFP-positive and the other EGFP-negative (internal control). Scale
bars, 10 lm. The number of cells counted for statistical analysis in
(c) and (d) were as followed: Vector ?CHX/-TRAIL = 905, Vector
?CHX/? TRAIL = 681, Bcl2 ?CHX/-TRAIL = 1288, Bcl2
?CHX/?TRAIL = 1146, NS ?CHX/-TRAIL = 924, NS ?CHX/
? TRAIL = 850, Bax/Bak ?CHX/-TRAIL = 1157, and Bax/Bak




reasoned that the caspase cascade may be important for
cellular extrusion.
Epithelial cellular extrusion requires caspase activity
for the proper formation and contraction
of the actomyosin ring
To test the role of caspase activity for activating apoptotic
cell extrusion, we inhibited caspase activation using the
pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp
(OMe)-ﬂuoromethyl-ketone (z-VAD-fmk) after UV irra-
diation or etoposide-treatment. As expected, we observed
an almost complete inhibition of apoptotic cell death, as
evaluated by caspase activation and DNA morphology
(Fig. 4a, c). Since either pharmacological or genetic inhi-
bition of caspase following apoptotic stimuli could lead to
other cell death mechanisms such as necrosis [25–29] or
caspase-independent cell death [30–33], we evaluated the
High Motility Group Box 1 (HMGB1) marker localization
to explore the viability of the z-VAD-fmk–treated UV-
irradiated cells. In living cells, HMGB1 is localized in the
nucleus of interphase cells. During apoptosis, HMGB1
remains in the fragmented nucleus or is released into the
cytoplasm. During necrosis or other forms of non-apoptotic
cell death, HMGB1 is released extracellularly and its
staining is lost [15, 34, 35].
To evaluate cell death in the presence of the pan-caspase
inhibitor, MDCK monolayers incubated with z-VAD-fmk
and treated with either UV-C or etoposide were immuno-
stained for HMGB1 in combination with DNA, active
caspase-3, cytochrome C or AIF (Fig. 4a). Very few cells
(1.5%) within these monolayers were apoptotic, as char-
acterized by positive caspase-3 and HMGB1 immuno-
staining, and chromatin condensation and fragmentation
(Fig. 4a, c). A higher percentage (5.3%) of cells with
z-VAD-fmk showed neither HMGB1 nor caspase-3 stain-
ing (Fig. 4a, c). The sum of both percentages corresponds
to the percentage of cells that would normally die through
apoptosis in the absence of z-VAD-fmk (Fig. 4c). Further,
the mitochondria in the HMGB1 negative cells appear to be
permeabilized, as cytochrome c was absent from mito-
chondria (Fig. 4a), conﬁrming that these cells were indeed
dying, although through a cell death mechanism different
from apoptosis. To determine whether these cells were
dying through caspase-independent cell death or necrosis,
we ﬁrst evaluated apoptosis inducing factor (AIF) locali-
zation. During caspase-independent cell death, AIF is
released from the mitochondrial outer membrane space and
translocates to the nucleus to mediate chromatin conden-
sation and large-scale DNA fragmentation [30, 36, 37].
Although AIF is absent from mitochondria, it does not
translocate into the nucleus, suggesting that these cells
were probably dying through necrosis, rather than caspase-
independent cell death (Fig. 4a). Their DNA appearance,
the absence of HMGB1 and caspase staining as well as
their positive staining for propidium iodide (PI), strongly
suggest that the z-VAD-fmk-treated cells were dying
through necrosis (Fig. 4a, e).
When evaluating whether cells extrude from monolayers
treated with z-VAD-fmk, we found that the small popula-
tion of apoptotic cells with caspase-3 activity undergo cell
extrusion, while the HMGB1 negative cells do not
(Fig. 4d). Instead, HMGB1 negative cells show a slight
accumulation of actin at the cell cortex where they contact
their neighboring cells, resembling a non-continuous actin
ring (Fig. 4b). Although the necrotic cells appear to form a
reduced actin extruding ring, they remain uncontracted in
the monolayer compared to control cells at 2 h post-irra-
diation (Fig. 4b, d).To determine whether these cells
eventually extrude, we ﬁlmed these cells by time-lapse
microscopy by treating MDCK cells stably expressing a
HMGB1-EGFP protein fusion with z-VAD-fmk and UV-C
(Fig. 4e). To monitor cell permeabilization, we added PI to
the culture medium. As previously observed, control
monolayers treated with the DMSO and UV irradiation
undergo apoptotic cell extrusion one to two hours post-
irradiation, as characterized by contracting, blebbing cells
surrounded by their neighbor cells in a rosette pattern
(Fig. 4e, asterisks). These apoptotic cells retain HMGB1 in
their nuclei and are negative for PI staining throughout the
extrusion process until the extruding ring has been closed
at 70–80 min after extrusion initiates (Fig. 4e, Supple-
mentary Movie 1). By contrast, when caspases are blocked,
cells undergo necrosis, lose HMGB1 and become PI-per-
meant, while no extrusion occurs (Fig. 4b, e, Note lack of
rosette pattern). In this case, necrotic cells have impaired
plasma membrane integrity and should compromise the
epithelium protective barrier, compared to monolayers
where apoptotic cells extrude. Nevertheless, although
necrotic cells are unable to trigger the extrusion machinery,
they are eventually removed from the epithelium by a
passive cell movement. The movement by constant cell
rearrangements in the epithelium acts to shove the necrotic
cells out of the way as their integrity declines (Fig. 4e,
Supplementary Movies 2, 3). These movies are represen-
tative of other movies, where apoptotic extrusion occurs
within 90 min, whereas necrotic cell removal can take up
to 5 h (Fig. S5 in Supplementary Material). This wide
variation is likely due to variance in the stochastic move-
ments of cells.
Discussion
Although several studies both in vivo and in vitro show a




little was previously known about how the pathways of
apoptosis and extrusion are linked. In this study, we found
that several intrinsic (UV irradiation, etoposide,
camptothecin and serum deprivation) and extrinsic (Fas-L
and TRAIL cytokines) apoptotic stimuli induce cells to
extrude from monolayers of two different cell lines
Fig. 4 Epithelial cellular extrusion requires caspase activity for
proper formation and contraction of the actomyosin ring. MDCK
monolayers incubated with 50 lM zVAD-fmk (caspase inhibitor) and
irradiated with UV-C were immuno-stained for DNA and HMGB1 as
well as active caspase-3, cytochrome c, AIF or actin (a, b). Apoptotic
(with active caspase-3) and necrotic cells (negative for both active
caspase-3 and HMGB1) as well as extruding and uncontracted cells
were quantiﬁed in monolayers subjected to treatments indicated in
(c) and (d). Results shown represent mean, where error bars
are ± SEM from three independent experiments. The number of
cells counted for statistical analysis in (c) and (d) were as followed:
DMSO -UV = 1832, DMSO ?UV = 1952, zVAD -UV = 1899,
and zVAD ?UV = 1875.MDCK monolayers stably expressing the
fusion HMGB1-EGFP were treated with UV-C irradiation with or
without zVAD (e) and time-lapsed every 10 min for 12 h. Propidium
iodide (PI) was added to monitor permeability of the dying cells.
Arrows in the top panels show an apoptotic extruding cell, where
asterisks in the second panel highlight rosette pattern formed around
the dying cell, which is characteristic of cell extrusion. Arrows in the
third panel show a necrotic, uncontracted cell, which loses its
HMGB1 (bottom panel) and becomes PI-positive and bursts. Arrow-
heads in the third panel point to another cell undergoing necrosis at a
faster rate than the cell with arrows. In the bottom panel, numbers
indicate four cells changing positions to illustrate the stochastic
movement of cells in the epithelium while yellow arrows indicate the




(MDCK and HBE). We also found that caspase activity is
required for cellular extrusion. When caspases are inhib-
ited, cells become necrotic and are removed from epithelia
by random epithelial cell movement. Taken together, our
results lead to a model whereby all known apoptotic signals
feed into a conserved step in the pathway important for
apoptotic extrusion—caspase activation (Fig. 5).
Caspases proteolytically inactivate or activate a variety
of targets, leading to the controlled pathway of morpho-
logical changes and break down of a cell during apoptosis.
Caspases also regulate several non-apoptotic processes
including activation and proliferation of T and B-lympho-
cytes, cell differentiation during keratinization of skin and
spermatogenesis, cell motility and cell shaping [39–41]. In
addition, caspase-8 activity has been suggested to play a
role in cell survival [42, 43]. In this work, we ﬁnd that
caspase activity is required to initiate the removal of dying
cells from epithelia. Our ﬁndings reveal a new role for
caspases in a non-apoptotic event—extrusion.
Two models were previously proposed to explain the
regulation of cellular extrusion. One model proposes that
the force driving cellular extrusion comes from the dying
cell itself and thus it is a cell autonomous mechanism [10,
44]. The second one, a non-cell autonomous model, pro-
poses that the contraction of an actomyosin ring formed in
the neighboring cells provides the main force for the
removal of the dying cell [4]. However, because extrusion
is a mechanism that requires multiple coordinated caspase-
dependent events, a combination of these two models may
occur (Fig. 5). During apoptosis, caspases target important
actin and myosin regulators such as Gas2, LIM-kinase 1
and ROCK, which activate contractile forces required for
apoptotic cell blebbing [45–49]. These forces, as initially
proposed by Mills et al. [10], could be an important com-
ponent of actomyosin contractions occurring during
extrusion. Therefore, even though contraction of the acto-
myosin ring in the surrounding cells is required for extru-
sion, contractions in the dying cell may also be required to
ensure efﬁcient extrusion (Fig. 5).
While contractions to remove the dying cell occur,
caspases could also control the reorganization of adherens
and tight junctions, which are required for extrusion. This
reorganization plays a crucial role during extrusion not
only for the release of the dying cell from the epithelium,
but also for the maintenance of the epithelial protective
barrier. As shown by Kessler and Mu¨ller [50, 51], caspases
trigger a progressive and orchestrated disassembly of
adherens junctions. Early in apoptosis, cleavage of b-
catenin promotes the removal of E-cadherin from the
membrane. Later in apoptosis, all adherens junction com-
ponents are removed from the membrane. At the same
time, while the apoptotic cell is released, the neighboring
cells form new adherens junctions, closing the gap the
apoptotic cell would leave. In addition, the detachment of
the apoptotic cell from the extracellular matrix is also
regulated by caspases [10].
Although caspase activity is required for cellular
extrusion, other upstream signals may be required to ini-
tiate early steps in extrusion activation. Indeed, we ﬁnd that
even when caspases are inhibited with zVAD, a non-con-
tinuous ring of actin still forms around the dying cell;
however, it is unclear whether this ring forms in the live or
dying cells. Therefore, other upstream signals could par-
tially participate in the formation of the actomyosin ring,
but without caspase activation, the extruding ring would
not fully form or contract (Fig. 5).
In our experiments when blocking caspases inhibited
apoptosis, cells instead become necrotic and did not
extrude, but were eventually removed by random move-
ments of surrounding cells. It is important to note, how-
ever, that other studies ﬁnd that necrosis of single cells due
to laser ablation heal by a purse-string mechanism that
mimics extrusion [38, 52]. Although this mechanism might
be different from extrusion, these cells may still contain
extrusion-inducing signals that the necrotic cells in our
study would have lost over time. Therefore, how an epi-
thelial cell dies within the epithelium could have signiﬁcant
effects on the barrier function of the epithelium. If a cell
Fig. 5 A model for apoptotic regulation of cellular extrusion. This
model illustrates pathways that can link apoptosis with extrusion.
Here, caspases may orchestrate the removal of the apoptotic cells by
activating several signals. Question mark suggests that other non-
apoptotic signals may also contribute to formation of actin extruding




dies by apoptosis or sudden necrosis, such as a wound, the
barrier will be preserved, whereas if it dies by necrosis
following impaired apoptosis, the barrier of the epithelium
could become compromised.
The fact that apoptosis connects with the extrusion
pathway at a late point in the apoptotic pathway ensures
that any apoptotic stimulus will feed into the extrusion
pathway. The requirement of caspase activity also suggests
that caspase activity functions as an important checkpoint
in the removal of cells from the monolayer only after a cell
has passed the point of no return in the apoptosis pathway.
Early events in the apoptosis pathway, therefore, might not
trigger extrusion as a way to give cells another chance to
ﬁx any potential threat before committing to apoptosis,
such as DNA damage, protein agglomeration, ER stress, or
damaged mitochondria.
Our ﬁndings establish the connection between apoptosis
and cellular extrusion and bring new insights in the
molecular basis of cellular extrusion. Our work also reveals
another non-apoptotic role for caspases, regulation of cel-
lular extrusion. However, further investigations will need
to determine which caspases participate in the activation of
extrusion and which factors targeted by caspases play
decisive roles during this event.
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BCL-2 REGULATION OF CELLULAR EXTRUSION 
 
3.1 Abstract 
In Chapter 2, I found that Bcl-2 overexpression inhibits both apoptosis and extrusion 
when apoptosis is induced by intrinsic apoptotic stimuli. Accordingly, I find here that 
inhibition of Bcl-2 with a BH3-mimetic drug is sufficient to induce apoptotic cell 
extrusion. I have also examined the effects of Bcl-2 on cell junctions to rule out non-
specific reasons that Bcl-2 may block cell extrusion and also find that it is required at 
mitochondria. Finally, I have helped develop a transgenic heat-shock inducible Bcl-2 
zebrafish line to test if Bcl-2 blocks extrusion in vivo. 
 
3.2 Introduction 
Although pro-apoptotic and anti-apoptotic proteins have a known role in regulating 
apoptosis, their role is not restricted to cell death. Bcl-2 family members have also been 
found to play roles in other cellular processes, such as cell cycle progression, DNA 
repair, autophagy and glucose homeostasis [1-6]. Caspases are catalytically involved in 
activation and proliferation of T and B lymphocytes, cell differentiation, cell motility, 
cell shaping [7-9], and possibly in cell survival [10-11]. 
In particular, the anti-apoptotic protein Bcl-2 binds a multitude of proteins that 
regulate a variety of different biological processes. In the same way that Bcl-2 binds the 
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pro-apoptotic Bax to prevent mitochondrial outer membrane permeabilization (MOMP) 
and block apoptosis, Bcl-2 can also bind and inhibit Beclin 1 on the endoplasmic 
reticulum (ER) to prevent autophagy [5]. 
I found in Chapter 2 that Bcl-2 overexpression inhibits apoptotic cellular extrusion 
induced by an apoptotic intrinsic stimulus in cell culture. To determine if Bcl-2 inhibition 
is sufficient to induce cellular extrusion, I examined if the Bcl-2 inhibitor, BH3-mimetic, 
HA 14-1, can induce apoptotic cellular extrusion. We also investigated if the ability of 
Bcl-2 to inhibit cellular extrusion is only a result of loss of cell junctions by Bcl-2. By 
targeting Bcl-2 overexpression to the mitochondria or the ER, we find that Bcl-2 
inhibition of extrusion occurs at mitochondria. In collaboration with Jean Marie 
Delalande in the lab, I also made a heat-shock inducible Bcl-2 transgenic zebrafish, 
which can be used to determine if Bcl-2 blocks extrusion in vivo as it does in cell culture 
cells. 
 
3.3 Material and methods 
3.3.1 Cell culture 
 MDCK II cells (gift from K. Matlin, University of Chicago, Chicago, IL) were 
cultured in Dulbecco's Modified Eagle Medium (DMEM) high glucose (Invitrogen 
11965-092) with 5% FBS, 2mM L-glutamine, 50 U/ml penicillin, 50 μg/ml streptomycin 
(all from Invitrogen) at 5% CO2, 37°C. 
 
3.3.2 Induction of apoptosis 
To induce apoptosis, MDCK monolayers were treated with 120 mJ/cm2 short-wave 
(UV-C) light, using a Spectrolinker (Spectroline) and incubated for 2 hours after 
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irradiation or by treating with 15 µM HA 14-1 for 30 min. To induce apoptosis in 
zebrafish Danio rerio, we incubated four-day old zebrafish larvae with 450 μg/ml G418 
(Invitrogen) in fish water (60 mg Instant Ocean mix per liter of distilled H2O) for 2 hours. 
 
3.3.3 Cell staining 
Cells were fixed with 4% formaldehyde in PBS for 20 min, permeabilized for 5 min 
with 0.5% Triton in PBS, rinsed thrice with 0.1% Triton in PBS, and blocked with AbDil 
(PBS with 0.1% Triton X-100 and 2% BSA) for 20 min before incubating with primary 
antibodies. Cells were then incubated with the following primary antibodies (diluted in 
AbDil) for 1 hour: 1:200 rabbit monoclonal anti active caspase-3 (BD pharmigen), 1:100 
rabbit monoclonal anti E-cadheren (Cell siganling), 1:100 mouse monoclonal anti β-
catenin (BD pharmigen), 1:400 rabbit polyclonal anti ZO-1 (Zymed), 1:100 rabbit 
polyclonal anti cytochrome c (Santa Cruz), 1:100 mouse monoclonal anti-Bcl-2 (Abcam) 
and 1:100 rabbit monoclonal anti-calnexin (Abcam). After washing coverslips 3 times in 
0.1% Triton X-100 in PBS, coverslips were incubated in secondary antibodies (all diluted 
1:100 in AbDil): Alexa Fluor® 488 goat anti-rabbit, Alexa Fluor® 568 goat anti-rabbit, 
Alexa Fluor® 568 goat anti-mouse and Alexa Fluor® 647 goat anti-rabbit (all from 
Molecular probes, Invitrogen). Along with secondary antibodies, we incubated the cells 
with 1 μg/ml Hoescht 33342 (Sigma-Aldrich) and 0.25 μg/ml Alexa Fluor® 568 
phalloidin or 0.25 μg/ml Alexa Fluor® 647 phalloidin (Molecular Probes, Invitrogen). 
After incubation with secondary antibody for 45 min, the coverslips were rinsed once 
with 0.1% Triton in PBS and then mounted on a micro slide (Gold Seal Products) using 




Fluorescence micrographs of MDCK monolayers were obtained using a Leica DM 
6000B microscope captured with a Micromax charge-coupled device camera (Roper 
Scientific). IP Lab Software was used to control the camera and to process images. 
Confocal micrographs were obtained using a TCS SP5 microscope (Leica). Zebrafish 
images were obtained using an Olympus SZX12 microscope and an Olympus S97809 
camera as well as a Nikon 90i microscope with a Retiga 2000R charge-coupled device 
camera (Q Imaging). All images were processed using Metamorph (GE Healthcare), 
Photoshop (Adobe) and Illustrator (Adobe) software. 
 
3.3.5 Immunoblot analysis 
Antibodies used for immunoblot analysis included monoclonal mouse anti-Bcl-2 
(Abcam), polyclonal rabbit anti-GFP (Invitrogen), polyclonal rabbit anti 2A peptide and 
monoclonal mouse anti-alpha tubulin (Sigma) and were diluted to 1:10,000 in PBST 
(0.05% Tween 20 in PBS) with 5% milk. 
 
3.3.6 DNA constructs 
Human Bcl-2 alpha isoform ORF (Open Biosystems) was PCR cloned and either 
inserted into the vector pEGFP-C1 (Clontech) to obtained the pEGFP-Bcl2 or 
recombined into the donor vector pDONR221 (Invitrogen) following company’s 
instructions. Similarly, the Bcl-2 mutants: Bcl2-ActA and Bcl2-cb5 (Gift from Dr. David 
Andrews [12]) were PCR cloned and recombined with into pDONR221. The obtained 
entry vectors, pDONR-Bcl2-221, pDONR-Bcl2-ActA-221 and pDONR-Bcl2-cb5-221 
were then recombined with the retroviral vector pMIG [13] modified to function as a 
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destination vector (Gift from Dr. Alana Welm [14]). The expression vectors pMIG-Bcl2, 
pMIG-Bcl2-ActA, pMIG-Bcl2-cb5 and the empty vector pMIG were used to produce 
retroviral particles. 
 
3.3.7 Fish transgenesis 
The p5E-hsp70 vector containing a 1.5-kb hsp70 promoter for heat-shock induction 
(5’ entry clone), the p3E-2A-EGFPCAAXpA vector containing the PTV1-2A peptide and 
EGFPCAAX (prenylated EGFP) plus SV40 late poly A (3’ entry clone) and the 
destination vector pDestTol2CG2 containing the cmlc2:EGFP transgenesis marker were 
kindly provided by Dr. Chi-Bin Chien [15]. Zebrafish Danio rerio Bcl-2 (zBcl-2, Open 
Biosystems) was PCR cloned and recombined into pDONR221 (Invitrogen) to create the 
middle entry clone pzBcl2-221. Recombination of entry clone vectors and the destination 
vectors were recombined, as previously indicated [15], to produce the transgenic Tol2 
vector pHsp70-zBcl2-2A-EGFPCAAX-CG2. The transgenic Tol2 vector along with Tol2 
transposase mRNA was microinjected into one-cell embryos as indicated [15]. Zebrafish 
larvae at 2 day post-fertilization were screened for transgenic green hearts using an 
Olympus SZX12 microscope. 
 
3.3.8 Statistical analysis 
The statistical analysis of data collected from three independent experiments was 
performed using the parametric unpaired two-tailed t test. In each graph, p values are 




3.4.1 Bcl-2 inhibition by HA 14-1 induces cellular extrusion 
I previously found that overexpression of Bcl-2 blocked cell extrusion and death 
when cells were induced to die with intrinsic apoptotic stimuli. To test if inhibition of 
Bcl-2 is sufficient to induce extrusion, we treated MDCK monolayers with the BH3 
mimetic, HA 14-1, which binds and inhibits Bcl-2 to induce apoptosis [16]. After 
treatment with HA 14-1, I scored the number of apoptotic extruding cells in MDCK 
monolayers by staining for DNA, actin and active caspase 3 (Fig. 3.1). HA 14-1 
increased the percentage of cells undergoing apoptotic cellular extrusion compared to a 
DMSO-treated control (Fig. 3.1). These results suggest that blocking Bcl-2 is sufficient to 
induce extrusion and that extrusion is most likely activated downstream of Bcl-2 
inhibition. 
 
3.4.2 The effect of Bcl-2 overexpression on cell junctions 
Our data shows that overexpression of Bcl-2 has the ability to block both apoptosis 
and cellular extrusion, whereas inhibition of Bcl-2 with HA 14-1 induces apoptotic cell 
extrusion, suggesting that apoptosis and extrusion are activated downstream Bcl-2 
inhibition. However, a report that Bcl-2 can disrupt β-catenin, E-cadherin and ZO-1 
localization [17] suggests that the ability of Bcl-2 to block extrusion is only due to 
indirect effects of disrupting epithelial junctions that are required for extrusion. We 
immunostained MDCK monolayers over-expressing Bcl-2 for β-catenin, E-cadherin, and 
ZO-1 to examine this possibility (Fig. 3.2a). I found no difference in the localization of 
these junctional proteins in cells over-expressing Bcl-2 in MDCK monolayers compared 
to their internal control cells (untransfected cells in the monolayers) (Fig. 3.2a). 
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Moreover, Bcl-2 expressing cells actively participate in the formation of the actomyosin 
ring during extrusion of apoptotic cells (Fig. 3.2b), suggesting that their junctions are 
functionally intact. These results suggest that Bcl-2 does not block extrusion by soley 
disrupting cell-cell junctions, but rather directly regulates extrusion through other signals. 
 
3.4.3 The effect of targeted expression of Bcl-2 on cellular extrusion 
Bcl-2 localizes to the mitochondria, ER and the outer nuclear membrane [18-20]. 
Localization of Bcl-2 at these different organelles is due to its transmembrane domain. 
Removal of this domain disrupts Bcl-2 localization at these organelles and becomes 
soluble in the cytoplasm [12]. Exchange of this transmembrane domain for that of 
bacterial ActA or cytochrome b5 (cb5) targets Bcl-2 to the mitochondria or ER, 
respectively [12]. These Bcl-2 mutants, named Bcl2-ActA and Bcl2-cb5, were used to 
determine that Bcl-2 regulates autophagy only at the ER [5]. 
To test where Bcl-2 acts to regulate extrusion, we targeted Bcl-2 over-expression to 
the mitochondria or the ER using the above Bcl-2 mutants (Fig. 3.3 and 3.4). Bcl2-ActA, 
Bcl2-cb5, and WT Bcl-2 were cloned into a bicistronic system with EGFP where the 
internal ribosome entry site (IRES) allows separate expression of our gene product and 
the reporter EGFP. Immunoblot analysis shows that MDCK cells transduced with 
retroviral vectors containing these constructs express similar levels of over-expressed 
Bcl-2 (Fig. 3.3a). To confirm that Bcl-2 had targeted to correct subcellular sites, I tested 
if Bcl-2 colocalized with markers for mitochondria (cytochrome c) or ER, (calnexin) (Fig 
3.3b). While WT Bcl-2 localizes to both mitochondria and ER, the Bcl-2 mutants 
localized to their respective targeted compartments (Fig. 3.3b). As previously established, 
WT Bcl-2 blocks apoptotic cellular extrusion (Fig. 3.4). While ER-targeted Bcl-2 fails to 
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block extrusion, mitochondria-targeted Bcl-2 inhibits cellular extrusion at the same rate 
as the WT Bcl-2 (Fig. 3.4b). This result suggests that Bcl-2 inhibits cellular extrusion at 
the mitochondria, supporting the hypothesis that the connection between apoptosis and 
extrusion occurs at or downstream of MOMP. 
 
3.4.4 Bcl-2 regulation of cellular extrusion in zebra fish Danio rerio 
In MDCK monolayers, Bcl-2 overexpression blocks apoptotic cellular extrusion, but 
it is not clear if this same regulation occurs in vivo. To test the role of Bcl-2 in zebrafish, 
we developed a heat-shock-inducible Bcl-2 transgenic zebrafish using the Tol2 
transposon system, Tol2kit [15]. We used the inducible heat shock promoter, Hsp70 
promoter to drive Bcl-2 overexpression, as constitutive over-expression could interfere 
with the development of the fish (Fig. 3.5a). To monitor Bcl-2 expression after heat 
shock, we made a bicistronic reporter construct containing the coding sequence for 
zebrafish Bcl-2 (zBcl-2) and a membrane localized EGFP (EGFP-CAAX), separated by a 
2A sequence (Fig. 3.5a). The 2A peptide mediates co-translational cleavage of proteins in 
2A multicistronic systems, allowing equimolar protein expression (Fig. 3.5a). Since our 
construct has an inducible and not a constitutive fluorescent reporter, screening of 
transgenic fish through fluorescent microscopy would be impossible. Therefore we 
recombined the inducible construct into a Tol2 destination vector that carries an EGFP 
reporter driven by the cmlc2 heart-specific promoter (Fig. 3.5a). The final recombination 
product along with Tol2 transposase mRNA was microinjected into one-cell stage 
embryos of Danio rerio zebrafish. Transgenic fish with green hearts (Fig. 3.5c, left top 
panel) were screened using a fluorescent microscope. To reduce abnormalities caused by 
the transgenesis, screened fish were outcrossed to WT fish. The F1 generation zebrafish 
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carrying green fluorescent hearts were then back-crossed and screen for offspring with a 
maximal heat shock response. A fraction of each green heart F2 population was subjected 
to heat shock and its zBcl-2 protein levels were analyzed by immunoblot using an anti-
2A peptide antibody or an anti EGFP antibody (Fig. 3.5b). Fluorescent microscopy 
verified localization of the membrane EGFP-CAAX after heat shock (Fig. 3.5, right 
panel). Only heat shocked zBcl-2 expressing F2 fish treated with G418 to induce 
apoptosis did not induce apoptosis, whereas the untreated siblings had numerous cells 
undergoing apoptosis, as judged by active caspase-3 immunostaining (Fig. 3.6a). We are 
now poised to test if the Bcl-2 over-expressing fish where cell death is blocked undergo 
extrusion or not. 
 
3.5 Discussion 
By binding a variety of proteins, Bcl-2 regulates several cellular mechanisms such as 
apoptosis and autophagy. We have found that Bcl-2 also regulates cellular extrusion 
induced by intrinsic stimuli. Here, we show that inhibiting Bcl-2 with HA 14-1 is 
sufficient to induce apoptotic cellular extrusion. By evaluating the localization of 
junctional proteins in Bcl-2 over-expressing cells, we show that inhibition of cellular 
extrusion by Bcl-2 is not due to an indirect effect of merely disrupting cell junctions. We 
also found that Bcl-2 regulates cellular extrusion at the mitochondria, not the ER, 
supporting our hypothesis that the connection between apoptosis and extrusion occurs 











































Figure 3.1 Inhibition of Bcl-2 by HA 14-1 induces apoptotic cell extrusion. 
MDCK monolayers untreated, mock-treated or treated with HA 14-1 were stained for 
DNA, actin and active caspase 3. Then, the number of apoptotic cells were counted and 
analyzed from three independent experiments where the p value < 0.002. 
  









































Figure 3.2 Bcl-2 over-expression does not disrupt cell junctions. 
To evaluate localization of junctional proteins in Bcl-2 overexpressing cells, MDCK 
monolayers with cells over-expressing EGFP-Bcl2 were immunostained for E-cadherin, 
β-catenin and ZO-1 (a). When the neighboring cells overexpress Bcl-2, they can still 
participate in extrusion of dying cells, suggesting that the junctions are also functionally 
intact. Red arrows show closed actin extruding rings. 
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Figure 3.3 Expression levels and localization of targeted Bcl-2 mutants. 
Immunoblots from MDCK cells transduced with the respective forms of Bcl-2 show that 
the expression levels of WT and Bcl-2 mutants are similar (a). In (b), confocal 
microscopy of cells in (a) shows localization of the respective forms of Bcl-2. Note that 
in (a) and (b) Bcl-2 antibody specifically recognizes only the transduced forms of Bcl-2 
(human) and not the endogenous one (canine). ActA TM targets Bcl-2 to mitochondria 
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Figure 3.4 Bcl-2 blocks apoptotic cellular extrusion at the mitochondria but not at the ER. 
MDCK cell monolayers expressing different forms of Bcl-2 were UV-irradiated and 
stained for DNA, actin and active caspase 3. Arrows show actin rings and active caspase 
3 staining of apoptotic extruding cells in upper and lower panels respectively (a). Note 
that while EGFP positive cells (Bcl-2 expressing cells) in WT and ActA are resistant to 
apoptotic cell extrusion, those in cb5 are not (a and b). Also, note that EGFP negative 
cells (non-expressing Bcl-2 cells) in all of the monolayers are not resistant to UV-induced 































Figure 3.5 Inducible zBcl-2 transgenic zebrafish. 
The pHsp70-zBcl2-2A-EGFPCAAX-CG2 vector (a) along with Tol2 transposase mRNA 
were microinjected into one-cell embryos. Fish larvae with green fluorescent heart were 
screened by fluorescent microscopy (c, left top panel). F2 transgenic and nontransgenic 
fish were heat-shocked and analyzed by immunoblotting to evaluate expression of zBcl2-
2A and its EGFP-CAAX reporter (b). Transgenic heat-shocked fish were also analyzed 
by fluorescent microscopy to evaluate heat-shock response (c, left panels) and EGFP-










































Figure 3.6 Bcl-2 inhibits apoptotic cell extrusion in vivo. 
F2 zBcl-2 transgenic and nontransgenic fish were incubated in G418 or DMSO and 
stained for DNA and active caspase 3 (a). Arrows in (a) show cells undergoing apoptosis. 
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During development and throughout adulthood, cellular extrusion plays crucial 
physiological roles: ensuring the maintenance of the epithelial protective barrier during 
limb and trachea development and homeostasis, driving dorsal closure during Drosophila 
embryogenesis and maintaining proper compartment for the photoreceptor in the retina of 
the eye [1-6]. Several studies show that cellular extrusion is linked to apoptosis in vivo 
and in vitro. Moreover, in all observed epithelia, induction of apoptosis triggers cellular 
extrusion. However, little was it done to understand this regulation. 
Two models that seem to contradict each other were proposed to explain how 
extrusion occurs during apoptosis. While the cell autonomous model suggests that the 
dying contracting cell drags its neighbors to fill in the gap [7, 8], the non-cell autonomous 
model proposes that the dying cell signals its surrounding cells to form and contract an 
actomyosin ring, which drive its removal from the monolayer [3]. These models 
constitute an important step for understanding how apoptosis initiates the extrusion 
response; however, several questions still remain. Which apoptotic signals are important 
for activating extrusion? Is extrusion activated in response to both intrinsic and extrinsic 
apoptotic stimuli? What component(s) of the apoptotic machinery triggers the extrusion 
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response? Is apoptosis required to initiate extrusion or can extrusion occur independently 
of apoptosis? Can other forms of cell death such necrosis activate cell extrusion? 
In this work, I found that several intrinsic (UV irradiation, etoposide, camptothecin 
and serum deprivation) and extrinsic (Fas-L and TRAIL cytokines) apoptotic stimuli 
trigger cellular extrusion in two different cell lines (MDCK and HBE), suggesting a 
universal connection between apoptosis and extrusion (Fig. 4.1). Also, by investigating 
different steps in the apoptosis pathway, I found that caspase activation is required for 
extrusion to take place. This finding explains the universal response of extrusion to 
different apoptotic stimulus as all apoptotic pathways funnel into activation of caspases 
(Fig. 4.1). It also shows a new role for caspases, the regulation of cellular extrusion. 
Caspases appear as an important checkpoint for cell removal, as only cells crossing the 
point of no return in the apoptosis pathway (caspase activation) will be removed from the 
epithelium, giving cells a second chance to fix any potential threat (DNA damage, ER 
stress, etc). By identifying the component of the apoptosis machinery that initiates the 
extrusion response, my work finally establishes the connection between apoptosis and 
extrusion: activation of caspase. Also, because actomyosin contractions triggered by 
caspases in the dying cell, as previously suggested, may be essential for extrusion [7], 
and because caspase activity is required for proper formation and contraction of the 
actomyosin ring, my work reconciles two models that for long seemed to be mutually 
exclusive (Fig. 4.1). 
I also found that necrotic cells resulting from caspase inhibition do not extrude. They 
remain in the epithelium and become permeable, potentially compromising the epithelial 
protective barrier. Nevertheless, necrotic cells are still cleared from epithelia by a passive 
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mechanism that involves random movements of cells in the epithelium (Fig. 4.2). 
Although cells in epithelial monolayers are connected to each other with no room left 
around, they do not remain static. Cells die and drag neighbor cells to fill that gap, they 
also push their neighbors away when they grow and divide. As a result, cells in epithelial 
monolayers constantly move in different directions resembling people in a rock concert. 
These stochastic movements of epithelial cells exert forces on the necrotic cell until it 
burst. Simultaneously, the adjacent cells exerting pressure take over its place, sealing the 
gap the necrotic cell has left (Fig. 4.2). This mechanism is different from extrusion as it is 
not executed by contraction of an actomyosin ring. Instead, the removal of necrotic cells 
relies on the stochastic movement of the epithelial cells and, unlike extrusion, no rosette 
arrangement of the neighbor cells take place (Fig. 4.2). Because of that, the time for 
removal of necrotic cells from monolayers is very random and varies dramatically when 
compared to the time of removal of apoptotic cells by extrusion. The requirement of 
caspase activity for extrusion suggests that other forms of cell death different from 
apoptosis might lack the ability to trigger cellular extrusion. Instead, cells dying through 
these mechanisms might be removed similarly to necrotic cells in our studies. 
Although necrotic cells resulting from caspase inhibition during apoptosis fail to 
extrude, other studies find that necrosis of single cells due to laser ablation heal by a 
purse-string mechanism that mimics extrusion [10, 11]. Although this mechanism might 
be different from extrusion, it is possible that necrosis induced by laser irradiation 
activates a caspase-independent pathway that leads to extrusion. The existence of a 
caspase-independent pathway might explain extrusion occurring in some live cells or 
where caspase activity is inhibited [3, 12-14]. In fact, in our work, when caspases are 
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inhibited during apoptotic cellular extrusion, a non-continuous actin ring is still formed in 
the interface between the necrotic cell and its neighbors, supporting this possibility. 
During necrosis caused by caspase inhibition, the caspase-independent pathway might be 
only partially activated and is not sufficient to complete extrusion. However, during 
extrusion of live cells or necrosis induced by laser ablation, activation of this pathway 
could be sufficient to drive cellular extrusion. Nevertheless, future studies need to be 
performed to explore this hypothesis. EGFP-actin expressing cells along with 
untransfected cells in a mosaic arrangement should be use to determine whether the non-
continuous actin accumulation around the uncontracted cells, resembling a contraction 
ring, is formed in the neighbor cells. That is, an untransfected cell undergoing necrosis 
surrounded by EGFP-actin expressing cell would help to determine whether the necrotic 
cell is inducing the formation of this actin ring-like structure. Staining for myosin II, 
another component of the extruding ring [3] would further support this hypothesis. To 
develop the caspase-independent pathway activated during extrusion of live cells or laser-
irradiation-induced necrosis, identification of actomyosin regulators should be performed. 
This will allow sequential identification of their activators and so on. 
In this dissertation, I show that caspase activity drives the removal of apoptotic cells 
by triggering both the formation and contraction of an actomyosin ring in the neighbor 
cells and the actomyosin contractions occurring in the dying cell. However, the 
importance of caspase activity during other aspects of extrusion, the release of the 
apoptotic cell from the epithelium, has been explored by others. During extrusion, while 
the dying cell is been squeezed to be removed out of the monolayer, cell junctions 
between the dying cell and its neighbor cells as well as that between the dying cell and 
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the extracellular matrix need to be disrupted in an organized and coordinated manner in 
such a way that the epithelial protective barrier is maintained. Using Drosophila as a 
model, Kessler and Müller [15, 16] demonstrated that caspases trigger a progressive and 
orchestrated disassembly of adherens junctions. During early stages of apoptosis, 
caspases cleave β-catenin, promoting partial removal of E-cadherin from the membrane. 
Later, all adherens junction components are removed from the membrane. At the same 
time, while the apoptotic cell is being released, the neighboring cells form new junctions, 
closing the gap the apoptotic cell would leave. In addition, the detachment of the 
apoptotic cell from the extracellular matrix is also regulated by caspases [7]. In this way, 
my work complements other’s findings and put together a major scope of the regulation 
of apoptotic cellular extrusion by caspases, the release of the dying cell and the 
contraction forces that drive removal of the cell from the monolayer. 
At the completion of this dissertation, we have established the connection between 
apoptosis and extrusion, caspase activity. We have also found a passive mechanism by 
which dead cells that fail to activate extrusion are cleared from epithelia. However, 
although our work brings new insight into the molecular basis of apoptotic cellular 
extrusion, several questions remain. For example, which caspases participate during 
apoptotic cell extrusion? During apoptosis, three executioner caspases (caspase 3, 6 and 
7) target several proteins for proteolysis, leading to the morphological changes associated 
with apoptosis. Out of this group, caspase 3 is required for DNA degradation and 
blebbing [17, 18]. This is not unexpected as caspase 3 proteolytically activate critical 
actomyosin regulators such as Gas2, gelsolin, and Rock1, whose roles have been 
previously established in actin-myosin dynamics during apoptotic cell blebbing [19, 20]. 
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As initially proposed by Mills et al [7], these contractions are important for extrusion 
because allow dragging of the neighboring cells by the contracting apoptotic cell, which 
is one of the component forces during extrusion (Fig 4.1). However, these actomyosin 
regulators, activated by caspase 3 during apoptosis, could also play important roles in the 
contraction of the actomyosin ring, the second component force during extrusion (Fig 
4.1). As previously showed, inhibition of Rock1 and myosin light chain kinase (MLCK) 
by the drugs Y-27632 and ML-9 respectively blocks extrusion of the apoptotic cell from 
the monolayer, supporting the importance of these regulators for the contraction of the 
extrusion ring [3]. Nevertheless, because Rock1 and MLCK are key regulators of 
apoptotic cell blebbing [21], it is necessary to understand whether they are required for 
contractions in the apoptotic cell, the extrusion ring or both. For that, the use of mosaic 
epithelial monolayers, where an untrasfected cell surrounded by cells expressing myosin 
or MLCK shRNAs with an EGFP reporter or vice versa, will help to better understand the 
role of these myosin regulators during extrusion. We believe that these myosin regulators 
are important for both component forces. In the apoptotic cell, Rock1 and MLCK are 
directly activated by caspases, inducing the first extrusion component force, contractions 
in the apoptotic cell. Caspase activation will lead to the formation and translocation of 
sphingosine-1-phosphate (S1P). Once translocated into the neighbor cells, S1P will 
induce the activation of Rock1 and MLCK for contraction of the extrusion ring 
(unpublished data). 
Therefore, the crucial role of caspase 3 for the activation of actomyosin regulators 
during apoptosis makes it an important candidate during apoptotic cellular extrusion, not 
only for driving the contraction forces in the dying cell, but also for the formation and 
 54 
translocation of the extruding signal that will trigger the formation and contraction of the 
actomyosin ring in the neighbor cells. The role of the caspase 3 during extrusion can be 
further explored by using specific caspase 3 inhibitors such as z-DEVD-fmk, or shRNA 
oligos to downregulate caspase 3 levels. In addition, an active form of caspase 3, under 
the regulation of an inducible promoter, could be used to test the sufficiency of caspase 3 
activity during cellular extrusion. Using a proteomics approach, cells expressing the 
active form of caspase 3 along with cells where caspase 3 is downregulated could be used 
to identify potential candidates targeted by caspase3 during cell extrusion.  
Although caspase 3 might be required to trigger the actomyosin contractions leading 
to removal of the dying cell, other caspases might coordinate the release of the dying cell 
from its neighbors and the extracellular matrix. As previously mentioned, caspases 
orchestrate the release of the dying cell during extrusion [7, 15, 16]. Cells lacking caspase 
3 do not contract but are still released [7], suggesting that the activity of other caspases is 
sufficient to coordinate the release of the dying cell during extrusion. It is possible that 
caspase 3 also participates in the release of the dying cell during extrusion but its role is 
dispensable or not required. 
A better understanding of extrusion during apoptosis and non-apoptotic cell contexts 
will allow us to explore its role in other biological processes such as wound healing, cell 
fate during differentiation and its potential role as a tumor suppressor pathway by 




































Figure 4.1 Apoptotic regulation of epithelial cellular extrusion. 
The proposed model shows the connection between apoptosis and extrusion: caspases. It 
illustrates the different tasks caspases perform during cellular extrusion: 1) formation and 
contraction of the extruding ring in the neighboring cells, 2) contractions in the dying cell 
and 3) remodeling of the cell junctions to release the apoptotic cell while maintaining the 
epithelial protective barrier. Question mark (?) points a potential alternative pathway to 
trigger formation and contraction of the extruding ring. MOMP stands for Mitochondrial 














Figure 4.2 Mechanism of epithelial cell removal 
Cells dying through apoptosis signal its neighbors to trigger its removal through an active 
mechanism of cell removal: cellular extrusion. In contrast, cells dying through necrosis 
do not trigger the extrusion response. Instead, they become permeable, potentially 
compromising the epithelial protective barrier. Eventually, the constant and random 
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